• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

Introduction to N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine (CAS No. 83304-60-3)

N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine, a compound with the chemical formula C₁₄H₁₇N, is a significant molecule in the field of pharmaceutical chemistry. This compound is characterized by its unique structural features, which include a benzyl group and a dimethoxyphenyl moiety. The presence of these functional groups makes it a valuable intermediate in the synthesis of various pharmacologically active agents. The CAS number 83304-60-3 uniquely identifies this compound and distinguishes it from other chemical entities.

The benzyl group in N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine contributes to the compound's solubility and stability, making it an ideal candidate for further derivatization and functionalization. The dimethoxyphenyl moiety, on the other hand, imparts specific electronic and steric properties that can influence its interactions with biological targets. These properties have been extensively studied in recent years, leading to a deeper understanding of its potential applications in drug development.

Recent research has highlighted the importance of N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine in the synthesis of novel therapeutic agents. Its structural framework has been utilized in the development of compounds with anti-inflammatory, anticancer, and antimicrobial properties. For instance, studies have demonstrated its role as a precursor in the synthesis of kinase inhibitors, which are crucial in treating various forms of cancer. The dimethoxyphenyl group has been shown to enhance binding affinity to target proteins, thereby improving the efficacy of these inhibitors.

The pharmaceutical industry has shown significant interest in this compound due to its versatility and potential therapeutic benefits. Researchers have explored its use in developing treatments for neurological disorders, where its ability to cross the blood-brain barrier is particularly valuable. Additionally, its derivatives have been investigated for their potential as antiviral agents, offering hope for new strategies in combating infectious diseases.

In terms of synthetic methodologies, N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine serves as a key intermediate in multi-step organic reactions. Its synthesis typically involves the reaction of benzaldehyde derivatives with appropriate nitrogen-containing reagents under controlled conditions. Advances in catalytic systems have further optimized these reactions, making them more efficient and environmentally friendly. These improvements have not only enhanced the yield but also reduced the formation of unwanted byproducts.

The compound's stability under various conditions has also been a subject of interest. Studies have shown that N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine maintains its structural integrity when exposed to light and oxygen, making it suitable for long-term storage and transportation. This stability is crucial for pharmaceutical applications where product shelf life is a critical factor.

From a regulatory perspective, the handling and use of N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine are governed by strict guidelines to ensure safety and efficacy. Manufacturers must adhere to Good Manufacturing Practices (GMP) to guarantee the quality and consistency of the final products. Additionally, rigorous testing protocols are employed to assess its compatibility with other pharmaceutical ingredients and its overall safety profile.

The future prospects of N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine are promising, with ongoing research exploring new applications and improving existing synthetic routes. The integration of computational chemistry and artificial intelligence has accelerated the discovery process by predicting potential drug candidates and optimizing their properties before experimental synthesis. This interdisciplinary approach has opened new avenues for innovation in pharmaceutical chemistry.

In conclusion, N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine (CAS No. 83304-60-3) is a versatile and valuable compound with significant implications in drug development. Its unique structural features and functional groups make it an ideal candidate for synthesizing novel therapeutic agents with broad applications in medicine. As research continues to uncover new possibilities, this compound is poised to play an even greater role in addressing global health challenges.

• 756474-36-9(N-(2-methoxybenzyl)-2-propanamine Hydrochloride)
• 69875-89-4(Benzyl-(2-methoxy-benzyl)-amine)
• 355816-10-3((2,5-Dimethoxybenzyl)(4-Methoxybenzyl)Amine)
• 20781-23-1(Bis(2,4-dimethoxybenzyl)amine)
• 6851-80-5(2-Methoxy-N-methylbenzylamine)
• 807343-01-7((2-methoxyphenyl)methyl(propyl)amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)